Starget Pharma
PrivateLast Round
Series A
Feb 18, 2026
Total Funding Raised
$33.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Starget Pharma operates in Healthcare & Life Sciences and is based in Ramat HaSharon. Its latest recorded funding round was a Series A round in February 2026.
Starget Pharma is a biotechnology company that develops AI-driven peptide radioligand therapies for the imaging and treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Starget Pharma Comparables
Compare Starget Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alpha-9 Oncology | 85% | |
| Ratio Therapeutics Inc. | 81% | |
| Aktis Oncology | 80% |
For institutional investors. Book with your work email.
Starget Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 18, 2026 | ||||
| Seed | Oct 23, 2024 | ||||
| Series A | Nov 30, 2021 |
For institutional investors. Book with your work email.
Starget Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The University of Texas MD Anderson Cancer Center | Series A, Seed |
| Cancer Focus Fund | Series A, Seed |
| Louisiana Economic Development Corporation | Series A |
| Biomedical Research Foundation of Northwest Louisiana | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 17, 2026
Grew 17% QoQ, from 18 to 21 employees.
- Jun 16, 2026
Monthly visitors increased 2603% MoM, reaching 1.1K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 20, 2026
Starget Pharma Inc. develops AI-designed peptide radioligands that home to tumors and deliver targeted radiation for metastatic cancers, with three candidates entering clinical trials in 2026.
- hiresAug 5, 2026
Starget Pharma Inc. appoints Oliver Sartor, MD, to its Scientific Advisory Board in Louisiana on Jul 28th '26, strengthening its scientific leadership as it advances multiple radioligand programs toward the clinic.
- hiresAug 5, 2026
Starget Pharma Inc. appoints Professor Michael Hofman, MBBS, FRACP, FAANMS, to its Scientific Advisory Board in Louisiana on Jul 28th '26, as it advances multiple radioligand programs toward the clinic from its AI-powered discovery platform.
For institutional investors. Book with your work email.
Starget Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Starget Pharma's valuation, stock price, and market status.
Is Starget Pharma a public or private company?
Starget Pharma is a private company.
What is the current stock price of Starget Pharma?
Starget Pharma is a private company, so its shares have no public market price. Caplight tracks Starget Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Starget Pharma worth (valuation)?
Valuation information for Starget Pharma is not publicly available.
Can I buy Starget Pharma stock?
Starget Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Starget Pharma's last funding round?
Starget Pharma's most recent funding round was Series A on February 18, 2026.
Who are the main investors in Starget Pharma?
Key investors in Starget Pharma include Cancer Focus Fund.
Will Starget Pharma IPO soon?
No public IPO plans have been announced for Starget Pharma.
How can I track Starget Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Starget Pharma's shares on secondary markets.